4-borono-2-fluorophenylalanine has been researched along with Brain Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Chen, YW; Hu, YS; Huang, WS; Lee, JC; Li, CY; Lin, CS; Lin, KH; Lo, YW | 1 |
| Campanella, R; Capuani, S; D'Amore, E; Fasano, F; La Bella, A; Lecce, M; Maraviglia, B; Migneco, LM; Pastore, FS; Porcari, P | 1 |
| Inaji, M; Ishii, K; Ishiwata, K; Kimura, Y; Matsumura, A; Momose, T; Nariai, T; Ohno, K; Yamamoto, T | 1 |
| Imahori, Y; Mineura, K; Takahashi, Y | 1 |
| Chang, PF; Chen, FD; Chen, JC; Deng, WP; Hwang, JJ; Lee, JS; Liao, AH; Liu, RS; Wang, HE | 1 |
| Chang, SM; Chen, JC; Hsu, FY; Liu, RS; Wang, HE | 1 |
| Imahori, Y; Mineura, K; Sasajima, H | 1 |
| Chang, CW; Chen, FD; Chen, JC; Chen, YF; Hsieh, CH; Hwang, JJ; Kai, JJ; Liu, RS; Wang, HE | 1 |
| Eskola, O; Havu-Aurén, K; Jääskeläinen, J; Kiiski, J; Kulvik, M; Lehtiö, K; Minn, H; Oikonen, V; Vähätalo, J; Vuorinen, V | 1 |
| Hiratsuka, J; Honda, C; Ido, T; Imahori, Y; Mishima, Y; Ueda, S | 1 |
| Fujii, R; Ido, T; Imahori, Y; Kusuki, T; Ohmori, Y; Ono, K; Ueda, S | 1 |
1 review(s) available for 4-borono-2-fluorophenylalanine and Brain Neoplasms
| Article | Year |
|---|---|
[Molecular imaging for brain tumor using positron emission tomography].
Topics: Amino Acids; Biological Transport; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carbon Radioisotopes; Cell Proliferation; Diglycerides; Electrons; Fluorine Radioisotopes; Humans; Neoplasm Staging; Oligodeoxyribonucleotides, Antisense; Phenylalanine; Phospholipids; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; RNA, Messenger | 2005 |
10 other study(ies) available for 4-borono-2-fluorophenylalanine and Brain Neoplasms
| Article | Year |
|---|---|
The importance of optimal ROIs delineation for FBPA-PET before BNCT.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Feasibility Studies; Humans; Phenylalanine; Positron-Emission Tomography | 2020 |
In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; Fluorine; Glioma; In Vitro Techniques; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Phenylalanine; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Tissue Distribution | 2009 |
PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Topics: Algorithms; Astrocytoma; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carbon Radioisotopes; Glioblastoma; Glioma; Humans; Methionine; Phenylalanine; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiotherapy Planning, Computer-Assisted | 2009 |
Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.
Topics: Adult; Aged; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Phenylalanine; Prognosis; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Topics: Animals; Autoradiography; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Fluorine Radioisotopes; Fructose; Glioma; Male; Phenylalanine; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed | 2004 |
MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma.
Topics: Animals; Boron Compounds; Brain Neoplasms; Fluorine Radioisotopes; Fructose; Glioma; Humans; Male; Phenylalanine; Positron-Emission Tomography; Rats; Rats, Inbred F344 | 2004 |
Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Topics: Animals; Blood-Brain Barrier; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Glioma; Injections, Intra-Arterial; Male; Mannitol; Metabolic Clearance Rate; Organ Specificity; Osmolar Concentration; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Distribution | 2005 |
Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
Topics: Adult; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurilemmoma; Neurofibromatoses; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue.
Topics: Boron; Boron Compounds; Brain; Brain Neoplasms; Fluorine Radioisotopes; Humans; Isotopes; Lymphatic Metastasis; Melanoma; Phenylalanine; Tomography, Emission-Computed | 1997 |
Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.
Topics: Astrocytoma; Boron Compounds; Brain Neoplasms; Cerebrovascular Circulation; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Phenylalanine; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |